Target intelligence / Profile preview

Musculoskeletal embryonic nuclear protein 1 (MUSTN1)

Target
MUSTN1
Molecular classification
Other (small nuclear protein, not assigned to classic protein families such as receptors, enzymes, GPCRs, ion channels, or transcription factors; sometimes described as a co-activator/co-regulator of transcription)
01

Overview

Musculoskeletal embryonic nuclear protein 1 is a small nuclear protein (~9.6 kDa, approx. 80-82 amino acids), present mainly in bone, cartilage, skeletal muscle, and tendon. It is evolutionarily conserved among vertebrates and expressed in both embryonic and adult tissues of the musculoskeletal system. MUSTN1 expression is regulated by the AP-1 family of transcription factors, including c-Fos, Fra-2, and JunD. Functional studies indicate that MUSTN1 is essential for normal muscle cell (myoblast) and cartilage (chondrocyte) differentiation, growth, and regeneration. It is not a classical transcription factor as it lacks a DNA-binding domain, but likely acts as a co-activator or co-regulator in transcriptional complexes during musculoskeletal development. Increased expression of MUSTN1 is seen during musculoskeletal tissue repair and in certain disease states, making it useful as a biomarker of lineage commitment and regeneration, although it currently has no direct drug interventions.

Other names
MUSTN1MustangMusculoskeletal embryonic nuclear protein 1musculoskeletal temporally activated novelMUSTANG
02

Biological functions

Cell differentiation (myogenic and chondrogenic)Regulation of muscle and cartilage developmentTissue growth and regenerationEmbryonic development (musculoskeletal lineage)Postnatal growth
03

Disease associations

Musculoskeletal pathology (arthritis, Duchenne muscular dystrophy, other myopathies)Bone fracture repair/regenerationClubfootMuscle pathology associated with diabetes
04

Biomarkers

Marker for musculoskeletal lineage cellsProposed for use in identifying differentiation or regeneration in musculoskeletal tissues

Beyond the preview

Go deeper on Musculoskeletal embryonic nuclear protein 1 (MUSTN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Musculoskeletal embryonic nuclear protein 1 (MUSTN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call